Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for several ...
New York Post25d
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...
Pharmaceutical Technology1mon
Egyptian Drug Authority approves Lilly and EVA’s insulin injection
The collaboration of Lilly and EVA Pharma began in 2022 to provide affordable insulin. Credit: © 2022 Eva Pharma All Rights Reserved. Eli Lilly and EVA Pharma have ...
Nasdaq1mon
Eli Lilly: Egyptian Drug Authority Approves Insulin Glargine Injection Manufactured By EVA Pharma
(RTTNews) - Eli Lilly and Company said the Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly (LLY). The ...
Turkmen Portal2mon
UNDP has handed over another batch of Lantus insulin to the Ministry of Health and Medical Industry of Turkmenistan
UNDP handed over another batch of Lantus insulin to the Ministry of Health and Medical Industry of Turkmenistan – 75,000 pre-filled syringes worth a total of US$330,000. The drug was purchased with ...
BBC1y
Drug giant Sanofi becomes latest to cap US insulin prices
Pharmaceutical giant Sanofi has capped the price of its insulin, becoming the last of three major manufacturers of the drug to curb soaring ... per month price cap on Lantus for those with private ...